Transfusion Medicine (Comprehensive, Limited) J, J1
|
|
- Valerie Simmons
- 5 years ago
- Views:
Transcription
1 Transfusion Medicine Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS). Transfusion Medicine (Comprehensive, Limited) J, J1 Procedure J J1 Challenges per Shipment ABO grouping 5 Rh typing 5 Antibody detection 5 Antibody identification 5 Compatibility testing 5 Red blood cell antigen detection 1 Category 1 CME CE Surveys J and J1 are designed for pretransfusion testing by manual techniques. See the Transfusion Medicine Automated Testing Survey (JAT) for automated instruments on page 156. For additional educational challenges to complement your proficiency testing, refer to Survey JE1 (see page 157). For competency assessment of technologists ability to perform comprehensive pretransfusion testing, please refer to Survey TMCA, Transfusion Medicine Competency Assessment Comprehensive Transfusion Medicine. Each shipment will include five 2.0-mL specimens of a 3% red blood cell suspension and five 3.0-mL corresponding serum specimens. Survey J shipments will also include one 2.0-mL donor red blood cell suspension. An education activity is planned that includes reading material found in the Participant Summary/Final Critique and online learning assessment questions. All laboratory staff can participate individually and earn free CME/CE credit without leaving the laboratory Surveys & Anatomic Pathology Education Programs Transfusion Medicine 155
2 Option 1 for Customer Contact Center New Cord Blood CBT Analyte CBT Challenges per Shipment Absolute CD34 2 Absolute CD3 2 Absolute CD45 2 Bacterial culture 2 % CD34+ 2 % CD45+ 2 CFU-GM 2 Fungal culture 2 Hematocrit 2 Hemoglobin 2 Mononuclear cell count 2 % CD3 2 Total nucleated cells 2 Total nucleated red cells 2 Viability 2 WBC count 2 Each shipment will include two specimens for the proficiency testing of assays required for the production of umbilical cord blood stem cell products. Transfusion Medicine Automated Testing JAT Procedure JAT Challenges per Shipment ABO grouping 5 Antibody detection 5 Rh typing 5 Antibody detection 5 Survey JAT is designed for automated blood banking instruments. For antibody identification and compatibility testing by manual techniques, refer to Survey J (see page 155). For additional educational challenges to complement your proficiency testing, refer to Survey JE1 (see page 157). For competency assessment of technologists ability to perform comprehensive pretransfusion testing, please refer to Survey TMCA, Transfusion Medicine Competency Assessment Comprehensive Transfusion Medicine. Each shipment will include five specimens. 156 Transfusion Medicine College of American Pathologists
3 Direct Antiglobulin Testing DAT Procedure DAT Challenges per Shipment Direct antiglobulin testing 3 Survey DAT is designed for laboratories performing direct antiglobulin testing as a stand-alone test or as part of any of the following work-ups: pretransfusion compatibility testing, transfusion reaction, autoimmune hemolytic anemia, and/or hemolytic disease of the newborn. Each shipment will include three 2.0-mL specimens of a 3-4% red blood cell suspension. For competency assessment of technologists ability to perform direct antiglobulin testing, please refer to Survey TMCAD, Transfusion Medicine Competency Assessment Direct Antiglobulin Test. Transfusion Medicine Educational Challenges JE1 Program JE1 Challenges per Shipment Educational challenge 1 Category 1 CME CE Survey JE1 provides maximum educational benefits for laboratories performing comprehensive Transfusion Medicine testing. A variety of Transfusion Medicine challenges comprise Survey JE1. These may include, but are not limited to, paper challenges, serum specimens for antibody detection and identification, red blood cell suspensions for ABO grouping, Rh typing, and direct antiglobulin testing, and/or 35mm slide challenges. An education activity is planned that includes reading material found in the Participant Summary/Final Critique and online learning assessment questions. All laboratory staff can participate individually and earn free CME/CE credit without leaving the laboratory. Product Fulfillment Group J 2008 Surveys & Anatomic Pathology Education Programs Transfusion Medicine 157
4 Option 1 for Customer Contact Center Transfusion Medicine Competency Assessment Comprehensive Transfusion Medicine TMCA Procedure TMCA Challenges per Shipment ABO grouping 2 Antibody detection 2 Antibody identification 2 Compatibility testing 2 Rh typing 2 Note: Shipments may be ordered individually. Survey TMCA is designed for laboratory directors and managers to assess the competency of their technical staff in performing routine pretransfusion testing. Shipments may be ordered individually or for an entire year. Intended responses will be mailed to participants approximately four weeks after receipt, enabling laboratory managers or directors to perform an evaluation of technologist performance. Each shipment of Survey TMCA will contain two 2.0-mL specimens of a 3% red blood cell suspension and two 3.0-mL corresponding serum specimens, along with one donor 3.0-mL 3% red blood cell suspension. Transfusion Medicine Competency Assessment Direct Antiglobulin Test TMCAD Procedure TMCAD Challenges per Shipment Direct antiglobulin testing 2 Note: Shipments may be ordered individually. Survey TMCAD is designed for laboratory directors and managers to assess the competency of their technical staff in performing direct antiglobulin testing. Shipments may be ordered individually or for an entire year. Intended responses will be mailed to participants approximately four weeks after receipt, enabling laboratory managers or directors to perform an evaluation of technologist performance. Each shipment of Survey TMCAD will contain two 2.0-mL specimens of a 3-4% red blood cell suspension. 158 Transfusion Medicine College of American Pathologists
5 Fetal Red Cell Determination HBF Analyte/Procedure HBF Challenges per Shipment F cell value 2 Hemoglobin F, qualitative (fetal screen) 2 Hemoglobin F, quantitative 2 The F cell value is compatible with flow cytometry methods. Qualitative (screen) Hemoglobin F is compatible with E-rosette testing for D(Rh o ) fetal red blood cells in the maternal circulation. Quantitative Hemoglobin F is compatible with Kleihauer-Betke and flow cytometry methods. Each shipment will include two 1.2-mL liquid stabilized red blood cell specimens. For competency assessment of technologists ability to perform fetal red cell quantitation, please refer to Survey TMCAF, Transfusion Medicine Competency Assessment Fetal Red Cell Quantitation. Transfusion Medicine Competency Assessment Fetal Red Cell Quantitation TMCAF Procedure TMCAF Challenges per Shipment Kleihauer-Betke 2 Fetal Screen 2 Note: Shipments may be ordered individually. Survey TMCAF is designed for laboratory directors and managers to assess the competency of their technical staff in performing qualitative and/or quantitative tests for hemoglobin F. Compatible methods include: for qualitative hemoglobin F: E-rosette testing for D(Rh o ) fetal red blood cells in the maternal circulation; and for quantitative hemoglobin F: Kleihauer-Betke and flow cytometry methods. Shipments may be ordered individually or for an entire year. Intended responses will be mailed to participants approximately four to six weeks after kit receipt, enabling laboratory managers or directors to perform a self-evaluation of technologist performance. Each shipment of Survey TMCAF will contain two 1.2-mL specimens of stabilized red blood cell suspensions Surveys & Anatomic Pathology Education Programs Transfusion Medicine 159
6 Option 1 for Customer Contact Center Platelet Serology PS Procedure PS Challenges per Shipment Antibody detection 3 Platelet crossmatch 3 Survey PS participants will crossmatch each plasma specimen provided with ten units of platelets from their institution and report the percentage of units that are serologically incompatible. Participants will also report results of an antibody screen. Note: A low concentration of sodium azide may be present in the specimens and may affect lymphocytotoxicity methods. Each shipment will include three 3.0-mL plasma specimens. This material is compatible with solid-phase red cell adherence, flow cytometry, EIA/ELISA, and RIA methods. Stem Cell Processing SCP Procedure SCP Challenges per Shipment Absolute CD3 2 Absolute CD34 2 Bacterial culture 2 % CD34+ 2 % CD45 2 CFU-GM 2 Fungal culture 2 Hematocrit 2 Mononuclear cell count 2 % CD3 2 Total nucleated cells 2 Total nucleated red cells 2 Viability 2 WBC count 2 Survey SCP is designed for laboratories processing and handling stem cells. The Survey will assess each laboratory s ability to determine if a stem cell product is suitable for use based on the results of the above analytes. The Survey will contain two specimens of peripheral blood for laboratory analysis. 160 Transfusion Medicine College of American Pathologists
7 Viral Marker Chemistry VMC Analyte VMC Challenges per Shipment Alanine aminotransferase (ALT/SGPT) 5 Cholesterol 5 Protein, total 5 Survey VMC is designed for laboratories performing viral markers testing and alanine aminotransferase, cholesterol, or total protein testing. Each shipment will include five 5.0-mL liquid plasma specimens. Transfusion-Related Cell Count TRC Procedure TRC Challenges per Shipment Platelet count (Platelet-Rich Plasma) 5 WBC count (Leukocyte-Reduced Platelet Suspension) 2 WBC count (Leukocyte-Reduced Red Blood Cell Suspension) 2 Survey TRC provides Hematology and/or Transfusion Medicine laboratories with proficiency testing material for various cell count procedures. The Platelet-Rich Plasma material can be utilized for both manual and automated platelet count methods. The Leukocyte-Reduced Red Blood Cell suspensions and Leukocyte-Reduced Platelet suspensions provide laboratories with an opportunity to assess their ability to perform low white blood cell (WBC) counts. Note: The Leukocyte-Reduced Red Blood Cell and the Leukocyte-Reduced Platelet materials must be used with a Nageotte chamber or flow cytometry. Each shipment will include five 1.2-mL suspensions of stabilized mammalian Platelets (Platelet-Rich Plasma), two 1.0-mL vials containing a Leukocyte-Reduced Red Blood Cell material, and two 1.0-mL vials containing a Leukocyte-Reduced Platelet material Surveys & Anatomic Pathology Education Programs Transfusion Medicine 161
8 Option 1 for Customer Contact Center Eluate Survey ELU Procedure ELU Challenges per Shipment Antibody elution 2 Survey ELU is designed for laboratories performing antibody elutions (for non-abo antibodies) as a part of an antibody identification workup or direct antiglobulin test. Each shipment will include two 2.0-mL 50% red blood cell suspension specimens for use in performing antibody elutions. Antibody Titer ABT, ABT1, ABT2 Analyte/Procedure ABT ABT1 ABT2 Challenges per Shipment Anti-A Titer 1 Anti-D Titer 1 Survey ABT is designed for laboratories performing red cell antibody titers as a part of any of the following workups: a prenatal antibody quantification workup; the management of recipients of ABO incompatible bone marrow transplants; to determine eligibility of O or B kidney transplant recipient candidates for receiving an A 2 kidney; and/or to assess the need and monitor the effect of plasma exchange in transplant recipients who are ABO incompatible with their donors. Survey ABT1 is designed for laboratories performing titers for Anti-A. Survey ABT2 is designed for laboratories performing titers for Anti-D. Laboratories ordering Surveys ABT, ABT1, or ABT2 will be able to report using a variety of techniques. Each shipment of Survey ABT will include one plasma specimen for anti-d titer with one corresponding titer cell (3% red blood cell suspension) and one plasma specimen for anti-a titer with one corresponding titer cell (3% red blood cell suspension). Each shipment of Survey ABT1 will include one plasma specimen for anti-a titer with one corresponding titer cell (3% red blood cell suspension). Each shipment of Survey ABT2 will include one plasma specimen for anti-d titer, with one corresponding titer cell (3% red blood cell suspension). 162 Transfusion Medicine College of American Pathologists
9 Transfusion-Transmitted Viruses Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS). The CAP and AABB provide jointly sponsored proficiency testing programs for laboratories involved in testing donor blood and diagnostic clinical patient samples for serologic markers of hepatitis and other transfusion-related diseases, as well as for parentage testing. These programs include Viral Marker Series 1, Series 2, and Series 3 (Surveys VM1, VM2, and VM3), and the Parentage Testing Programs (PAR, PARF). For assistance in determining which Viral Marker Series is appropriate for your laboratory s needs, contact a CAP Customer Contact Center Representative at option 1. AABB/CAP Viral Markers Series 1 VM1 Analyte VM1 Challenges per Shipment Anti-HAV, IgM 5 Anti-HAV, total 5 Anti-HBc, IgM 5 Anti-HBc, total 5 Anti-HBs 5 Anti-HCV 5 Anti-HIV-1 5 Anti-HIV-1/2 5 Anti-HIV-2 5 HBsAg 5 Survey VM1 is designed for laboratories performing general viral marker testing. Reporting areas for HIV-1 and HIV-2 Western Blot testing will be provided. Each shipment will include five 3.5-mL liquid serum specimens. Note: Survey VM1 material is not compatible with rapid anti-hiv-1 or anti-hiv1/2 kits. Please enroll in Surveys RHIV, RHIVW, AHIV, or AHIVW (page 165) if using a rapid kit. Product Fulfillment Group VM Handle with Care Specimens included in this section may contain pathogens and must be handled with extreme care. These specimens must be dealt with and disposed of only by trained laboratory personnel. Treat specimens as though they are capable of transmitting hepatitis and/or other blood-borne diseases Surveys & Anatomic Pathology Education Programs Transfusion-Transmitted Viruses 163
10 Option 1 for Customer Contact Center AABB/CAP Viral Markers Series 2 VM2 Analyte VM2 Challenges per Shipment Anti-HBe 5 HBeAg 5 Each shipment will include five 3.5-mL liquid serum specimens. Product Fulfillment Group VM AABB/CAP Viral Markers Series 3 VM3 Analyte VM3 Challenges per Shipment Anti-CMV 3 Anti-HTLV-I/II 3 HIV-1 p24 antigen 3 Reporting areas for HTLV-I Western Blot testing will be provided. Each shipment will include three 3.5-mL liquid serum specimens. Product Fulfillment Group VM New Viral Markers Series 4 VM4 Analyte VM4 Challenges per Shipment Anti-Trypanosoma cruzi (Chagas Disease) 2 Each shipment will include two 1.0 ml specimens for the qualitative detection of antibodies to T. cruzi. Product Fulfillment Group VM 164 Transfusion-Transmitted Viruses College of American Pathologists
11 Anti-HIV-1/2 AHIV, AHIVW Analyte AHIV AHIVW Challenges per Shipment Anti-HIV-1/2 5 Anti-HIV-1/2, waived 2 Survey AHIV is designed for laboratories performing anti-hiv-1/2 testing using a rapid method. Survey AHIVW is designed for laboratories performing anti-hiv-1/2 testing using a waived method; space will be provided for reporting anti-hiv-1/2 for up to five different locations within your institution. Anti-HIV-1 RHIV, RHIVW Analyte RHIV RHIVW Challenges per Shipment Anti-HIV-1 5 Anti-HIV-1, waived 2 Survey RHIV is designed for laboratories performing anti-hiv-1 testing using a rapid method. Survey RHIVW is designed for laboratories performing anti-hiv-1 using a waived method; space is provided for reporting anti-hiv-1 results for up to five different locations within your institution. Note: Both Survey RHIV and RHIVW are compatible with the OraQuick Rapid HIV-1 Antibody Test kit by OraSure Technologies and the Uni-Gold Recombigen HIV kit by Trinity Biotech. Survey RHIV is compatible with the MedMira Reveal HIV-1 Antibody Test kit. Nucleic Acid Testing NAT Procedure NAT Challenges per Shipment Nucleic acid testing for HBV 5 Nucleic acid testing for HIV 5 Nucleic acid testing for HCV 5 Nucleic acid testing for West Nile Virus 5 Survey NAT is designed for blood donor centers currently performing HBV, HCV, WNV, and/or HIV nucleic acid testing on donor units. Results will be reported qualitatively. Each shipment will include five 6.0-mL plasma specimens Surveys & Anatomic Pathology Education Programs Transfusion-Transmitted Viruses 165
12 Option 1 for Customer Contact Center Parentage/Relationship Testing Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS). AABB/CAP Parentage/Relationship Testing PAR, PARF Analyte/Procedure PAR PARF Challenges per Shipment Calculation challenge 1 DNA testing (PCR) 4 Each shipment of Survey PAR will include three liquid whole blood paternity trio specimens. Survey PARF will include three blood-stained filter paper paternity trio specimens. A buccal swab will be provided for a second alleged father challenge in Surveys PAR and PARF. Participants may report results for short tandem repeats (STRs), Y-STRs, as well as the conclusions. Note: The calculation exercise is a paper challenge. 166 Parentage/Relationship Testing College of American Pathologists
Histocompatibility. HLA Serologic Typing (Class I/II) ABO, HLAS, HLAS Surveys & Anatomic Pathology Education Programs
www.cap.org Histocompatibility Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS). HLA Serologic Typing (Class I/II) ABO, HLAS,
More informationDAT-B 2015 Direct Antiglobulin Test
EVALUATION DAT-B 2015 Direct Antiglobulin Test INSTITUTION: ATTENTION: CAP NUMBER: 7181660-01 Kit# 1 KIT INFORMATION: Kit ID: 28002258 10/12/2015 11/16/2015 Next Mailing Date: 2/22/2016 COPIED TO: LAP
More informationLaboratory Results Summary
Laboratory Results Summary Laboratory CO1033AI Test event 2 of 3 CAP LAP Number 7181660 Page Print Date 9 / 10 2008/Jul/04 Program Syphilis (SYPH435) Results Deadline 2008/Jun/24 Subscription ID Analyte
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Schedule of Accreditation 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK National Infection Service, Public Health England Colindale 61 Colindale Avenue London NW9 5EQ Contact: Dr Sanjiv
More informationREFERENCE LABORATORY. Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays.
I. REFERENCE LABORATORY HOURS OF OPERATION: Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays. All Reference Lab procedures are subject to
More informationScreening donors and donations for transfusion transmissible infectious agents. Alan Kitchen
Screening donors and donations for transfusion transmissible infectious agents Alan Kitchen Aim Not to teach you microbiology To provide and awareness of the big picture To provide an understanding of
More information2008 CAP TODAY Q & A
2008 CAP TODAY Q & A Q. How often should we document hematology competencies to ensure consistency of morphologic observations for manual differentials and fluids? Should we do this every six months or
More informationThe testing of Donated Blood and Components at NHSBT
The testing of Donated Blood and Components at NHSBT NHSBT is responsible for collecting all donated blood and platelets in England, then processing into components before issuing to client hospitals.
More informationAnswering your daily challenges. in the ELISA technology I N FECTI OUS DISEASES. bioelisa
Answering your daily challenges in the ELISA technology I N FECTI OUS DISEASES bioelisa RETROVIRUS HIV is the cause of the most important global pandemic. Due to the lack of vaccination, early diagnosis
More informationBlood Component Testing and Labeling
Blood Component Testing and Labeling Each donor unite must be tested and properly labeled before its release for transfusion. Required Tests: In most blood banks, pretransfusion testing involves determining
More informationPerform Gram stain only. Select Survey D5, Gram Stain
www.cap.org Bacteriology This flowchart is provided as a guide for ordering the appropriate Bacteriology Surveys for your laboratory s testing menu. In order to meet CLIA requirements for the subspecialty
More informationDirect Antiglobulin Test (DAT)
Exercise 8 Direct Antiglobulin Test (DAT) Objectives 1. State the purpose for performing the DAT. 2. State what a positive DAT indicates. 3. List the reagents which are used for performing the DAT. 4.
More informationQUALITY CONTROL Infectious Disease
QUALITY CONTROL Infectious Disease 1 Infectious Disease Quality Control The human based material used in the production of our Quality Controls is sourced from the Taiwan Blood Services Foundation (TBSF).
More informationDIAGNOSTIC SERVICES MANITOBA
DIAGNOSTIC SERVICES MANITOBA YEAR IN REVIEW JANUARY DECEMBER 2012 CANADIAN BLOOD SERVICES MANITOBA DIAGNOSTIC SERVICES SENIOR STAFF AND CONTACT INFORMATION MEDICAL DIRECTOR Debra Lane MD, FRCPC 204.789.1079
More informationLaboratory Diagnosis of Viral Infections. G. Jamjoom 2005
Laboratory Diagnosis of Viral Infections G. Jamjoom 2005 Five Main Techniques: Virus Culture and Isolation Serology Rapid Detection of Viral Antigens Detection of Viral Nucleic Acid Electron Microscopy
More informationHEPATITIS B NON-IMMEDIATE NOTIFICATION EPIDEMIOLOGY PROGRAM
HEPATITIS B NON-IMMEDIATE NOTIFICATION EPIDEMIOLOGY PROGRAM Event Name: Event Time Period: ACUTE Clinical Presentation (CDC 2012): CDC Event (2012): HEPB Lifelong immunity An acute illness with a discrete
More informationTRANSFUSION ASSOCIATED DISEASE, RECALL, OR COMPLICATION INVESTIGATION POLICY I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION:
I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION: A. TRANSFUSION RELATED FATALITY: FDA and MEDIC must be notified immediately, and subsequently in writing, when a possible transfusion related
More informationCASE STUDIES IN CLINICAL APPLICATIONS OF THERAPEUTIC PLASMA EXCHANGE
CASE STUDIES IN CLINICAL APPLICATIONS OF THERAPEUTIC PLASMA EXCHANGE Eric Rosa, MLS (ASCP) CM Medical Laboratory Scientist Transfusion Service April 18, 2018 Objectives Explain the process of a therapeutic
More informationNon-reproductive tissues and cells Recommending authority/ association
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Tested pathogen Donor test/ technique
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More informationTable of Contents (continued)
Emerging Molecular and Immunohematology Blood Typing, Grouping And Infectious Disease NAT Screening Assays And Companies Developing New Technologies and Products Table of Contents 1. Blood Typing and Grouping
More informationNon-reproductive tissues and cells
Ministry of Health: Institute for Transplantation and Biomedicine / Colour key VIRAL HIV 1 and HIV 2 Hepatitis B Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More
More informationTransfusion Reactions. Directed by M-azad March 2012
Transfusion Reactions Directed by M-azad March 2012 Transfusion Reactions are Adverse reactions associated with the transfusion of blood and its components Transfusion reactions Non-threatening to fatal
More informationOHIOHEALTH Laboratory Services INPATIENT, ED AND OTHER HOSPITAL BASED PATIENT CRITICAL VALUE NOTIFICATION LIST
11/5/2018 OHIOHEALTH Laboratory Services INPATIENT, ED AND OTHER HOSPITAL BASED PATIENT CRITICAL VALUE NOTIFICATION LIST Test Critical Low Critical High Alerting CHEMISTRY Amylase > 400 U/L Emergency Dept
More informationControls & Calibrators. Disease Quality Controls
Controls & Calibrators Infectious Disease Quality Controls Infectious Disease Quality Controls A broad selection of controls designed to monitor assay precision of hepatitis, retrovirus, sexually transmitted
More informationDiagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)
Diagnostic Methods of HBV infection Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Hepatitis B-laboratory diagnosis Detection of HBV infection involves
More informationThe Alphabet Soup of Viral Hepatitis Testing
The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,
More informationA written order to request the performance of a laboratory test can be initiated by the following parties:
Requests/Reporting Requests for Laboratory Services A written order to request the performance of a laboratory test can be initiated by the following parties: Staff physicians and dentists who have been
More informationPILOT STUDY OF ANTIGEN MATCHING FOR AUTOIMMUNE HEMOLYTIC ANEMIA
PILOT STUDY OF ANTIGEN MATCHING FOR AUTOIMMUNE HEMOLYTIC ANEMIA Sharon Rice & Fred Plapp Saint Luke s Hospital Kansas City, MO CENTRALIZED TRANSFUSION SERVICE Antibody identification Antibody titer Antigen
More informationAPPROACH TO RISK MANAGEMENT IN MEDICAL PRACTICE: STANDPOINT OF THE BLOOD TRASFUSION*
11 APPROACH TO RISK MANAGEMENT IN MEDICAL PRACTICE: STANDPOINT OF THE BLOOD TRASFUSION* Hisami IKEDA** Asian Med. J. 44(1): 11 21, 2000 Abstract: In the field of blood transfusion, risk management is defined
More informationDuration: 12 months May to April
SPECIALIST CERTIFICATE IN TRANSFUSION SCIENCE PRACTICE PROGRAMME OF STUDY OVERVIEW Example only Duration: 12 months May to April This document serves as a general programme overview only. To ensure you
More informationCLIA APPROVED PROFICIENCY TESTING PROGRAMS ACCUTEST, INC. P.O. Box 999 Westford, Massachusetts (800)
ACCUTEST, INC. P.O. Box 999 Westford, Massachusetts 01886 (800) 665-2575 MICROBIOLOGY Bacteriology Aerobic Culture and Identification Antibiotic Susceptibility Testing Direct Antigen Detection Gram Stain
More informationThe Technical Aspects of Pathogen Testing in Canada. Nancy Angus Canadian Blood Services Director, Testing
PERMISSON TO USE: Please note that, by making their presentations available on-line, primary authors have agreed to share their presentations. However, should you want to use some of the data or slides
More informationBlood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD
Blood transfusion Dr. J. Potgieter Dept. of Haematology NHLS - TAD General Blood is collected from volunteer donors >90% is separated into individual components and plasma Donors should be: healthy, have
More informationNon-reproductive tissues and cells
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legally binding on national level More stringent testing - recommended on national level Not legally binding
More informationStructure and duties of Blood service
NATIONAL CENTER FOR TRANSFUSION MEDICINE Prevalence of infectious diseases among Mongolian blood donors Namjil Erdenebayar General director of The National Center for Transfusion Medicine, Mongolia NCTM,
More informationto be notified: all parties involved in the graduated plan procedure. Annexes
Paul-Ehrlich-Institut Postfach 63207 Langen, Germany To all marketing authorisation holders of cellular blood preparations and therapeutic single plasmas as well as authorisation holders of stem cells
More informationKhalid Alquthami (Correspondence) Regional Lab, Makkah. Saudi Arabia
1 Regional Lab, Makkah. Saudi Arabia stract: Clinical specificity and genotype/subtype detection of viruses using the Cobas TaqScreen MPX system V 2.0, which is a nucleic acid test (NAT) that uses multiples
More informationGuidance for Industry
Guidance for Industry Advisement for the Use of Gen-Probe Procleix Ultrio Plus Assay for NAT Testing on Cadaveric Donors Release Date: 08/03/14 American Medical Education and Research Association 4757
More informationNon-reproductive tissues and cells
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding on national level More stringent - recommended on national level Not legy binding and not recommended on
More informationTest Critical Low Critical High Alerting Category
Test Critical Low Critical High Alerting CHEMISTRY Amylase > 400 U/L Emergency Dept only Amylase, Pancreatic >300 U/L Emergency Dept only Bicarb (Carbon Dioxide) 40 mmol/l Bilirubin, Total
More informationJOB AID CRITICAL VALUES AND TESTS W/O MICRO CRITICAL TESTS. Always call results for the following test(s):
Facilities: NoCo Laboratories JOB AID CRITICAL VALUES AND TESTS W/O MICRO CRITICAL TESTS Always call results for the following test(s): CONSTITUENT Ethylene Glycol (Performed at CU) Time Interval (from
More informationFor more information about how to cite these materials visit
Author(s): Robertson Davenport, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/
More informationCord Blood Bankers are. Angie Yost, MT(ASCP) CM 2016 ASCLS-MO CLMA Spring Meeting
Cord Blood Bankers are Angie Yost, MT(ASCP) CM 2016 ASCLS-MO CLMA Spring Meeting Objectives Cord blood 101 Manufacturing and cryopreservation Characterization testing Why Do We Need Cord Blood? Each year,
More informationEC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK
National Institute for Biological Standards and Control (NIBSC) EC Certificate - Full Quality Assurance System Approval Certificate Annex IV (excluding sections 4 and 6) of Council Directive 98/79/EC on
More informationPublic Health, Infections and Transplantation
Public Health, Infections and Transplantation Dr Kerry Chant Chief Health Officer & Deputy Director General Population and Public Health NSW Ministry of Health May2014 Public Health Infection and Transplantation
More informationReporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey
Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey This questionnaire consists of three sections: A. Collection and
More informationBlood Product Modifications: Leukofiltration, Irradiation and Washing
1. Leukocyte Reduction Definitions and Standards: o Process also known as leukoreduction, or leukofiltration o Applicable AABB Standards, 25th ed. Leukocyte-reduced RBCs At least 85% of original RBCs
More informationCORD BLOOD TRANSPLANTATION STUDY CBU EXCLUSION AND QUARANTINE RELEASE FORM
(Any answer of Yes indicates exclusion) 1. Informed Consent and Maternal/Infant Demographics a. Lack of confirmation of signed and witnessed informed consent 1 Yes 2 No Is the following information missing
More informationHepatitis A virus (HAV)
Volume 3, Issue 1 (Jan 2010) Editor s note Happy New Year and welcome to the first issue of QA Highlights of year 2010! In this issue, we are happy to bring to you Hepatitis Infection and Clinical Detection
More informationHIV Testing Technology and the Latest Algorithm
HIV Testing Technology and the Latest Algorithm David Warshauer, PhD, D(ABMM) Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene HIV Testing has changed over time Patients with
More informationReflex Test Protocols
UCH Clinical Laboratory Reflex Test Protocols Blood Bank Prepare RBCs for Transfusion (aka Crossmatch) N/A No Antibody Screen ordered Antibody Screen Direct Antiglobulin Test (DAT) Polyspecific DAT Positive
More informationNon-reproductive tissues and cells
Colour key Tested pathogen VIRAL Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legy binding on national level More stringent testing - recommended on national level Not
More informationLaboratory Values, Critical. ThedaCare. Date Last Reviewed: 4/5/2018 Reviewing Body(s): Quality; Laboratory Leadership
Laboratory Values, Critical ThedaCare Policy & Procedure Policy Title: Laboratory Values, Critical Policy Number: 694 Location(s): All ThedaCare Department(s): Laboratory Date Last Reviewed: 4/5/2018 Reviewing
More informationVM-A 2011 Viral Markers
EVALUATION VM-A 2011 Viral Markers INSTITUTION: ATTENTION: CAP NUMBER: 7181660-01 Kit# 1 KIT INFORMATION: Kit ID: 23929821 1/3/2011 2/8/2011 Next Mailing Date: 9/2011 COPIED TO: LAP CAP LEGEND: Exception
More informationBrrrr, It s Cold In Here
Brrrr, It s Cold In Here Kate Grogan, MD Transfusion Medicine Fellow Physician, BloodworksNW 4/24/15 Patient 20 year old female Viral illness Presents one week later with severe hemolysis Hgb 5.6 Increased
More informationWithin 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma
Test Name *Minimum Collection Tubes Sample Stability ABO/Rh Blood Typing 50 µl cells EDTA whole blood (lavender-top) Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma
More informationNLBCP-017 INDIRECT ANTIGLOBULIN CROSSMATCH TUBE METHOD. Issuing Authority
Government of Newfoundland and Labrador Department of Health and Community Services Provincial Blood Coordinating Program INDIRECT ANTIGLOBULIN CROSSMATCH TUBE METHOD Office of Administrative Responsibility
More informationMary Berg, M.D. Medical Director, Transfusion Services Associate Professor of Pathology University of Colorado Hospital
Transfusion Reactions/Complications Mary Berg, M.D. Medical Director, Transfusion Services Associate Professor of Pathology University of Colorado Hospital Acute Transfusion Reactions Can be seen with
More informationPROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8
Clinical Laboratory Improvement Amendments (CLIA) Brochure # 8 PROFICIENCY TESTING DOs and DON Ts NOTE: Congress passed the Clinical Laboratory Improvement Amendments (CLIA) in 1988 establishing quality
More informationNon-reproductive tissues and cells Recommending authority/ association
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Non-reproductive tissues and cells VIRAL
More informationWe are pleased to present the new Leaflet bioelisa Menu and Instrumentation, with reference
NEWS BK NEWS# 390/ MKT DATE : 13-07-2016 TITLE : New Leaflet bioelisa Menu and Instrumentation Dear colleagues, We are pleased to present the new Leaflet bioelisa Menu and Instrumentation, with reference
More informationWHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: OraQuick HCV Rapid Antibody Test Kit WHO reference number: PQDx
WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT Product: OraQuick HCV Rapid Antibody Test Kit WHO reference number: PQDx 0244-055-00 OraQuick HCV Rapid Antibody Test Kit with product codes 1001-0270
More informationStep-by-Step Instructions For OraQuick HCV Rapid Antibody Test
Step-by-Step Instructions For OraQuick HCV Rapid Antibody Test Complexity: WAIVED for fingerstick whole blood and venipuncture whole blood. A Certificate of CLIA Waiver is required to perform the test
More informationCryopreserved Human Hepatocytes (Cat # HP-F)
Certificate of Analysis Cryopreserved Human Hepatocytes (Cat # HP-F) This CoA represents a single Lot specific batch of cells. For details of current Lots available please contact us. Lot#: H0434 Gender
More informationHepatitis C Best Practice Guidelines For Local Health Departments
Hepatitis C Best Practice Guidelines For Local Health Departments LHDs are responsible for investigating and reporting all physician reported cases of acute hepatitis C (HCV). For clients known to have
More informationINVESTIGATION OF ADVERSE TRANSFUSION REACTIONS NLBCP-006. Issuing Authority
Government of Newfoundland and Labrador Department of Health and Community Services Provincial Blood Coordinating Program INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS Office of Administrative Responsibility
More informationCenter for Biologics Evaluation and Research
Center for Biologics Evaluation and Research Current Activities Future Directions Washington, DC January 25, 2010 Karen Midthun, MD Acting Director, CBER CBER Our Mission To ensure the safety, purity,
More informationTransfusion therapy: what is new with respect to safety and control of iron loading? Yesim AYDINOK
Transfusion therapy: what is new with respect to safety and control of iron loading? Yesim AYDINOK Following the Policy of the National Regulation 3.3, page 17, on CME disclosures, dated 5 November 2009,
More informationPrivate Patients Pricelist
Private Patients Pricelist Valid 1 January 2017-31 December 2017 INF-ACC-006 1043973 Rev 0 (01/06/17) Reg No. 2000/026390/08 Private Diagnostic Services Nappi 10580 Packaging R75.14 R85.66 15016 Low Ionic
More informationCORD BLOOD TESTING AND HDFN A CASE STUDY. Eric Rosa, MLS (ASCP) CM University of Kansas Hospital April 20, 2016
CORD BLOOD TESTING AND HDFN A CASE STUDY Eric Rosa, MLS (ASCP) CM University of Kansas Hospital April 20, 2016 BACKGROUND KU Hospital policy: run ABO/Rh (front) type + Direct Antiglobulin test on cord
More informationRisks and Benefits of Blood Transfusions. Objectives. Red Cells (Erythrocytes) Understand the following:
Risks and Benefits of Blood Transfusions Patient and Family Conference Aplastic Anemia & MDS International Foundation July 10-12 th, 2009 Indianapolis, Indiana Susan M. Carson RN, MSN, CPNP Childrens Hospital
More informationViral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a
Viral hepatitis Supervised by: Dr.Gaith presented by: Shaima a & Anas & Ala a Etiology Common: Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Less common: Cytomegalovirus EBV Rare: Herpes
More informationOfficial Journal of the European Communities COMMISSION
16.5.2002 EN Official Journal of the European Communities L 131/17 COMMISSION COMMISSION DECISION of 7 May 2002 on common technical specifications for in vitro-diagnostic medical devices (notified under
More informationNon-reproductive tissues and cells
Colour key Minimum requirements as set out in Directive 2004/23/EC and its technical Directives (particularly 2006/17/EC) More stringent -legally binding, applies for all donations and all donor profiles
More information10/18/2012. A primer in HLA: The who, what, how and why. What?
A primer in HLA: The who, what, how and why What? 1 First recognized in mice during 1930 s and 1940 s. Mouse (murine) experiments with tumors Independent observations were made in humans with leukoagglutinating
More informationA Transfusion Reaction What Do I Do Now? Judith A. Sullivan, MS, MT(ASCP)SBB, CQA(ASQ) ASCLS Region III Triennial Meeting Birmingham AL
A Transfusion Reaction What Do I Do Now? Judith A. Sullivan, MS, MT(ASCP)SBB, CQA(ASQ) ASCLS Region III Triennial Meeting Birmingham AL This promotional educational activity is brought to you by Ortho
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091650 Age 49 Years Gender Male 29/8/2017 120000AM 29/8/2017 100248AM 29/8/2017 105306AM Ref By Final HEATITIS, VIRAL, COMREHENSIVE ANEL HEATITIS A ANTIBODY (ANTI
More information8/28/2018. Disclosures. Objectives. None. Automation to PreciseType and Everything in Between
Automation to PreciseType and Everything in Between Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles None Disclosures Objectives Describe the application of molecular testing
More informationAutomation to PreciseType and Everything in Between. Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles
Automation to PreciseType and Everything in Between Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles None Disclosures Objectives Describe the application of molecular testing
More informationBlood Components & Indications for Transfusion. Neda Kalhor
Blood Components & Indications for Transfusion Neda Kalhor Blood products Cellular Components: Red blood cells - Leukocyte-reduced RBCs - Washed RBCs - Irradiated RBCs Platelets - Random-donor platelets
More informationSee external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091606 Age 24 Years Gender Male 30/8/2017 92800AM 30/8/2017 94631AM 31/8/2017 90306AM Ref By Final HEATITIS A & B VIRUS EVALUATION HEATITIS A ANTIBODY (ANTI HAV),
More informationInvestigation of Transfusion Complications
1.0 Principle To investigate suspected transfusion complications. 2.0 Scope and Related Policies 2.1. There shall be policies and procedures for documentation, reporting, evaluation and follow-up of all
More informationDIAGNOSTIC AUTOMATION, INC.
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationBlood Screening Assays. CTS lab locations where assays are performed are indicated by alpha codes D, P, and T.
Blood Screening Assays CTS lab locations where assays are performed are indicated by alpha codes D, P, and T. D= performed in Dallas lab FEI: 3002580251 P= performed in Phoenix lab FEI: 3000204058 T= performed
More informationTRANSFUSION REACTION EVALUATION
Lab Dept: Test Name: Transfusion Services TRANSFUSION REACTION EVALUATION General Information Lab Order Codes: Synonyms: CPT Codes: Test Includes: TRXR Transfusion Complication Workup; Hemolytic reaction
More information2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies
2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies Submitted by: Malaysia Policy Dialogue and Workshop on Attaining a Safe and Sustainable Blood Supply Chain Manila, Philippines 30 September 1
More informationBlood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood?
What is blood transfusion? A blood transfusion is a safe, common procedure in which blood is given through an intravenous (IV) line in one of the blood vessels. A blood transfusion usually takes two to
More informationINSTRUCTIONS FOR BLOOD BANK INSPECTION CHECKLIST AND REPORT CMS-282
Note to Surveyors: INSTRUCTIONS FOR BLOOD BANK INSPECTION CHECKLIST AND REPORT CMS-282 This form consists of portions of the FDA-2609. These portions are the only parts of the FDA-2609 that have been approved
More information1. The minimum hemoglobin concentration in a fingerstick from a male donor is: a g/dl (120g/L) b. 12.5g/dL (125g/L) c. 13.5g/dL (135g/L) d.
1. The minimum hemoglobin concentration in a fingerstick from a male donor is: a. 12.0 g/dl (120g/L) b. 12.5g/dL (125g/L) c. 13.5g/dL (135g/L) d. 15.0g/dL (150g/L) 2. A cause for permanent deferral of
More informationACMG/CAP Cytogenetics CY
www.cap.org Cytogenetics Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services ACMG/CAP Cytogenetics CY Analyte CY Challenges per Shipment
More informationUnderstanding Transfusion Medicine
Understanding Transfusion Medicine Every minute of every day, blood is on a critical journey A Reference Guide for Journalists Overview of Transfusion Medicine Every second, three people across the world
More informationReflex Test Protocols
Blood Bank Prepare RBCs for Transfusion (aka Crossmatch) N/A No Antibody Screen ordered Antibody Screen Direct Antiglobulin Test (DAT) Polyspecific DAT Positive polyspecific DAT IgG DAT, C3 DAT Fetal Cell
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091608 Age 26 Years Gender Female 30/8/2017 92900AM 30/8/2017 94717AM 31/8/2017 90216AM Ref By Final HEATITIS ACUTE VIRUS CONFIRMATION HEATITIS A ANTIBODY (ANTI HAV),
More informationSimulated ABO & Rh Bood Typing Lab Activity Student Study Guide
TM Simulated ABO & Rh Bood Typing Lab Activity Student Study Guide BACKGROUND Agglutinogens (Antigens): Agglutinogens are substances found on the surface of erythrocytes. Agglutinins (Antibodies): Agglutinins
More informationTRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE MEETING October2010. Issue Summary
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE MEETING 28-29October2010 Issue Summary Informational Topic: FDA s Geographic Donor Deferral Policy to Reduce the Possible Risk of Transmission
More informationAccuSet HBV Worldwide Performance Panel
PACKAGE INSERT 0805-033 INTENDED USE The is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot HBV test methods. Characterized samples
More information